Open AccessPSEUDOTUMOR CEREBRI COMPLICATING MULTISYSTEM INFLAMMATORY SYNDROME IN CHILD
Author(s) -
Hasnaa Almiaadi,
AUTHOR_ID,
Nadia Echcharii,
Nabila Chekhlabi,
N. Dini,
AUTHOR_ID,
AUTHOR_ID,
AUTHOR_ID
Publication year - 2022
Publication title -
international journal of advanced research
Language(s) - English
Resource type - Journals
ISSN - 2320-5407
DOI - 10.21474/ijar01/14025
Subject(s) - medicine , pseudotumor cerebri , leukocytosis , vomiting , cerebrospinal fluid , acetazolamide , differential diagnosis , intracranial pressure , papilledema , pneumonia , pathology , pediatrics , surgery , anesthesia
Purpose :To report a case of pseudotumor cerebri in a Child associated with coronavirus disease. Methods : A previously 12 year old boy presented to our hospital with a 5 days history of fever,headache,vomiting and general malaise.Initial laboratory investigation revealed significantly elevated neutrophilic leukocytosis and markers of inflammationwere significantly elevated, pharyngeal swab for severe acute respiratory syndrome coronavirus (SARS-CoV 2) by polymerase chain reaction was negative , while anti-sars-CoV-2 antibody was highly reactive.Neuro-ophtalmic examination revealed a visual accuity of 20/20 in both eyes with bilateral papilloedema.Neurogical examination was otherwise normal,MRI of the brain and magnetic resonnance venogram revealed abnormalities consistent with increased intracranial pressure.The opnening pressure of cerebrospinal fluid was 40 cmH2O and CSF composition was normal. Results : Based on our patients symptom the diagnostic of pseudotumor cerebri associated with multisystem inflammatory syndrome in child was made and the child was traited with oral acetazolamide.Edema of the optic disc regressed following therapy Conclusion : In conclusion pseudotumor cerebri syndrome may be seen in the content of SARS-CoV-2 infection and should be kept in the differential diagnosis for headache and vision loss in this population. Clinicians need to be aware of this potential neuro-ophtalmic complication in MIS-c diagnosis and treatment can prevent visual loss.